Humalog 200 Units/ml KwikPen (insulin lispro) important safety information for patients
Humalog 200 Units/ml KwikPen, solution for injection in pre-filled pen
Last Updated on eMC 05-Dec-2016 View changes | Eli Lilly and Company Limited Contact details
Having problems opening this PDF?
Download Acrobat Reader
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine. It is written for patients and gives information about taking or using a medicine. It is possible that the leaflet in your medicine pack may differ from this version because it may have been updated since your medicine was packaged.
Please click on the link to the left to view the PIL in PDF format.
Certain risk materials on this website are intended for use by healthcare professionals only.
By proceeding you are confirming that you are a healthcare professional.
Want to avoid this message? If you are a Healthcare professional, REGISTER or LOGIN and you will not have to self-certify when you access Risk Minimisation Materials.
Risk Materials
VIEW
Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.
Send us feedback
If you would like to make a comment or send us feedback on this material, click here.
CLOSE THIS PANEL
Eli Lilly and Company Limited
Address
Lilly House, Priestley Road, Basingstoke, Hampshire, RG24 9NL
Fax
+44 (0)1256 775 858
Medical Information Fax
+44 (0)1256 775 569
Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Active ingredients
Legal categories
This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue